RETN and Hyperglycemia: Hyperglycemia can contribute to tumor-related inflammation by triggering the release of pro-inflammatory cytokines such as interleukin-6 (IL-6), interferon γ (IFN-γ), tumor necrosis factor-alpha (TNF-α), and resistin [40].